Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/MAO.0b013e3182814e92 | DOI Listing |
Eur J Neurol
January 2025
Brain and Mind Centre, University of Sydney, Camperdown, New South Wales, Australia.
Lasers Med Sci
January 2025
Department of Plastic and Reconstructive Surgery, Korea University College of Medicine, Korea University Anam Hospital, Seoul, South Korea.
Xanthelasma palpebrarum (XP), characterized by soft, yellowish plaque primarily on the eyelids, is often associated with lipid metabolism disorders. XP can cause aesthetic concerns that affect social interactions and requires careful treatment evaluations due to potential complications and associations with systemic conditions. We aimed to assess the efficacy of and recurrence rates with erbium:yttrium aluminum garnet (Er:YAG) laser therapy in the treatment of XP.
View Article and Find Full Text PDFAesthetic Plast Surg
December 2024
Department of Plastic and Reconstructive Surgery, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui Province, People's Republic of China.
Background: Xanthelasma palpebrarum (XP) is a common eyelid condition. Various treatment modalities exist, each with its own merits and drawbacks. Managing larger lesions poses increased challenges.
View Article and Find Full Text PDFJ Clin Lipidol
November 2024
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan (Drs Tada, Usui, Sakata, and Takamura).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!